or Try an Advanced Search...

    Technical Analysis for IMMP - Immutep Limited

    Grade Last Price % Change Price Change
    C 3.03 2.36% 0.07
    IMMP closed up 1.37 percent on Friday, May 17, 2024, on 58 percent of normal volume.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical IMMP trend table...
    Date Alert Name Type % Chg
    Gapped Up Strength 2.36%
    Inside Day Range Contraction 3.77%
    Wide Bands Range Expansion 3.77%
    Outside Day Range Expansion 7.45%
    Wide Bands Range Expansion 7.45%
    Gapped Up Strength 7.45%
    Boomer Buy Setup Bullish Swing Setup 3.41%
    Inside Day Range Contraction 3.41%
    Wide Bands Range Expansion 3.41%
    Gapped Up Strength 3.41%
    Older End-of-Day Signals for IMMP ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Upper Bollinger Band 13 minutes ago
    Up 5% 13 minutes ago
    Upper Bollinger Band Resistance 13 minutes ago
    Up 1 ATR 13 minutes ago
    New 52 Week High 25 minutes ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    IMMP Chart by TradingView
    Basic chart:

    Profile

    Prima Biomed Ltd is a biotechnology company. It is engaged in the development of immunotherapeutic products for cancer and autoimmune disease. Their operations are based in Australia and Europe.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Cancer Autoimmune Disease Therapeutic Products

    Is IMMP a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 15 Immutep Presents Data from Safety Lead-in Phase of AIPAC-003 at ESMO Breast 2024
    May 2 Positive Initial Clinical Data Reported from Immutep’s Efti Combined with Radiotherapy and Checkpoint Inhibitor from Phase II Trial in Soft Tissue Sarcoma
    May 1 Immutep: Realizing The Expected Catalysts, With More To Come
    Apr 29 Immutep Quarterly Activities Report Q3 FY24
    Apr 24 Immutep reports promising efti/Keytruda data for head and neck cancer
    Apr 24 Why Australian Cancer Biotech Firm Immutep Stock Is Soaring On Wednesday?
    Apr 24 Immutep Announces Positive Preliminary Topline Results from TACTI-003 Cohort B
    Apr 18 Immutep Appoints Leading Research Institute to Conduct First-in-Human Phase I Study of IMP761
    Apr 17 Immutep Receives Positive Feedback from the Spanish Medicines Agency for Upcoming TACTI-004 Registrational Trial in Metastatic Non-Small Cell Lung Cancer
    Mar 27 Immutep Limited (ASX:IMM): Is Breakeven Near?
    See more IMMP news...

    Comments

    S

    SociableGnat503 9 months ago

    Any thoughts on what to expect here based on the chart? The volume looks quite low here. 

    0 Reply
    T

    TraderMike 9 months ago

    looks range-bound to me

    0 Reply
    S

    SociableGnat503 9 months ago

    What does that mean, short term pain but long term gain? 

    0 Reply
    T

    TraderMike 9 months ago

    It means it's stuck in a range -- going sideways between about 1.9 & 2.4

    0 Reply
    S

    SociableGnat503 9 months ago

    One can hope that it will ultimately pop given the potential and cash runway. 

    0 Reply
    T

    TraderMike 9 months ago

    Hope is not a plan 😁

    0 Reply
    S

    SociableGnat503 9 months ago

    It's why I will never be rich....lol 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 3.09
    52 Week Low 1.58
    Average Volume 226,724
    200-Day Moving Average 2.21
    50-Day Moving Average 2.60
    20-Day Moving Average 2.78
    10-Day Moving Average 2.94
    Average True Range 0.19
    RSI (14) 61.24
    ADX 35.96
    +DI 25.63
    -DI 9.86
    Chandelier Exit (Long, 3 ATRs) 2.53
    Chandelier Exit (Short, 3 ATRs) 2.71
    Upper Bollinger Bands 3.15
    Lower Bollinger Band 2.40
    Percent B (%b) 0.75
    BandWidth 27.07
    MACD Line 0.11
    MACD Signal Line 0.11
    MACD Histogram 0.0058
    Fundamentals Value
    Market Cap 351.89 Million
    Num Shares 119 Million
    EPS -0.35
    Price-to-Earnings (P/E) Ratio -8.46
    Price-to-Sales 81.76
    Price-to-Book 3.10
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 3.17
    Resistance 3 (R3) 3.19 3.13 3.13
    Resistance 2 (R2) 3.13 3.08 3.12 3.12
    Resistance 1 (R1) 3.05 3.05 3.02 3.03 3.11
    Pivot Point 2.99 2.99 2.98 2.98 2.99
    Support 1 (S1) 2.91 2.94 2.88 2.89 2.81
    Support 2 (S2) 2.85 2.91 2.85 2.80
    Support 3 (S3) 2.77 2.85 2.79
    Support 4 (S4) 2.75